Karen Kaucic

Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors

Catherine Delbaldo, Éric Raymond, Karina Vera et al. · Investigational New Drugs · 2007 · 101 citations

Pharmacy, Oncology, Pharmacokinetics +17

EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies

Deirdre O’Mahony, John C. Morris, Maryalice Stetler‐Stevenson et al. · Clinical Cancer Research · 2009 · 59 citations · Full text

Life Sciences, Hematology, Immunology +17

Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition

Bob T. Li, Bobby Daly, Mary Gospodarowicz et al. · Nature Medicine · 2022 · 52 citations

Medicine, Oncology, Translational Sciences +14

Induction of GM1a/GD1b synthase triggers complex ganglioside expression and alters neuroblastoma cell behavior; a new tumor cell model of ganglioside function

Lixian Dong, Yihui Liu, Anamaris M. Colberg‐Poley et al. · Glycoconjugate Journal · 2011 · 39 citations · Full text

Medicine, Cancer Biology, Cell Biology +8

Low complex ganglioside expression characterizes human neuroblastoma cell lines

Simone Hettmer, Stephan Ladisch, Karen Kaucic · Cancer Letters · 2005 · 38 citations · Full text

Medicine, Cell Biology, Neuroscience +9